[Treatment of inadequate cerebral circulation. A critical review].
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000150:complications; D001809:Blood Viscosity; D001929:Brain Edema / Q000188:drug therapy; D002245:Carbon Dioxide / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D003911:Dextrans / Q000627:therapeutic use; D005860:Germany, West; D006333:Heart Failure / Q000150:complications; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D002534:Hypoxia, Brain / Q000503:physiopathology; D008353:Mannitol / Q000627:therapeutic use; D008875:Middle Aged; D012121:Respiration, Artificial; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000925:Anticoagulants; D000959:Antihypertensive Agents; D003911:Dextrans; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D008353:Mannitol
Behandlung der cerebralen Mangeldurchblutung. Eine kritische Ubersicht